Passage Bio COO Jill Quigley to depart Dec 31, 2021; separation agreement signed

Passage BIO, Inc.

COO Jill Quigley voluntarily departs Dec 31, 2021 to pursue other interests; no disagreement over business.
Separation agreement includes 12-month base salary lump sum, 12-month COBRA, 2021 target bonus, equity acceleration.
Her COO responsibilities will be assumed by other members of the executive team.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jill Quigley

Chief Operating Officer

PASG · Passage BIO, Inc.

Effective: 2021-12-31
Filed: November 1, 2021, 7:59 PM ET

On November 1, 2021, Passage Bio, Inc. (the “ Company ”) announced the voluntary transition of Jill Quigley, the Company’s Chief Operating Officer, from the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jill Quigley departed as Chief Operating Officer at Passage BIO, Inc..

Action: departing
Role: Chief Operating Officer

Exact text from the filing

On November 1, 2021, Passage Bio, Inc. (the “ Company ”) announced the voluntary transition of Jill Quigley, the Company’s Chief Operating Officer, from the Company.

View on SEC.gov

Passage BIO, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-21-013927

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.